Distinct Requirements for TrkB and TrkC Signaling in Target Innervation by Sensory Neurons
Overview
Authors
Affiliations
Signaling by brain-derived neurotrophic factor (BDNF) via the TrkB receptor, or by neurotrophin-3 (NT3) through the TrkC receptor support distinct populations of sensory neurons. The intracellular signaling pathways activated by Trk (tyrosine kinase) receptors, which in vivo promote neuronal survival and target innervation, are not well understood. Using mice with TrkB or TrkC receptors lacking the docking site for Shc adaptors (trkB(shc/shc) and trkC(shc/shc) mice), we show that TrkB and TrkC promote survival of sensory neurons mainly through Shc site-independent pathways, suggesting that these receptors use similar pathways to prevent apoptosis. In contrast, the regulation of target innervation appears different: in trkB(shc/shc) mice neurons lose target innervation, whereas in trkC(shc/shc) mice the surviving TrkC-dependent neurons maintain target innervation and function. Biochemical analysis indicates that phosphorylation at the Shc site positively regulates autophosphorylation of TrkB, but not of TrkC. Our findings show that although TrkB and TrkC signals mediating survival are largely similar, TrkB and TrkC signals required for maintenance of target innervation in vivo are regulated by distinct mechanisms.
Generation of innervated cochlear organoid recapitulates early development of auditory unit.
Xia M, Ma J, Wu M, Guo L, Chen Y, Li G Stem Cell Reports. 2022; 18(1):319-336.
PMID: 36584686 PMC: 9860115. DOI: 10.1016/j.stemcr.2022.11.024.
Pulling back the curtain: The hidden functions of receptor tyrosine kinases in development.
Clark J, Soriano P Curr Top Dev Biol. 2022; 149:123-152.
PMID: 35606055 PMC: 9127239. DOI: 10.1016/bs.ctdb.2021.12.001.
Lan C, Wu Y, Wang N, Luo Y, Zhao J, Zheng Y J Cell Mol Med. 2021; 25(20):9609-9616.
PMID: 34545688 PMC: 8505836. DOI: 10.1111/jcmm.16905.
Johnson C, Hashim M, Bailey C, Byrd J, Kogut M, Arsenault R Poult Sci. 2020; 99(6):2955-2966.
PMID: 32475430 PMC: 7597693. DOI: 10.1016/j.psj.2020.03.012.
The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers.
Shulman D, Dubois S Paediatr Drugs. 2020; 22(2):189-197.
PMID: 31965543 DOI: 10.1007/s40272-020-00380-9.